Annual Drug Patent Expirations for TEKTURNA+HCT
Tekturna Hct is a drug marketed by Noden Pharma and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
TEKTURNA HCT drug price trends.
Drug patent litigation for TEKTURNA HCT.
This drug has one hundred and sixteen patent family members in thirty-nine countries.
The generic ingredient in TEKTURNA HCT is aliskiren hemifumarate; hydrochlorothiazide. One supplier is listed for this compound. Additional details are available on the aliskiren hemifumarate; hydrochlorothiazide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
